CENTESSA PHARMACEUTICALS PLC — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8a847e10-c332-40d3-aca5-69bb9db6ca53/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-207.7M | 2025-01-01 – 2025-12-31 | evidence 0001847903-26-000025 |
| FY 2024 | $-201.1M | 2024-01-01 – 2024-12-31 | evidence 0001847903-25-000051 |
| FY 2023 | $-171.3M | 2023-01-01 – 2023-12-31 | evidence 0001847903-24-000054 |
| FY 2022 | $-212.3M | 2022-01-01 – 2022-12-31 | evidence 0001847903-23-000063 |
| FY 2021 | $-374.1M | 2021-01-30 – 2021-12-31 | evidence 0001847903-22-000022 |
| FY 2020 | $-10.4M | 2020-01-01 – 2020-12-31 | evidence 0001847903-22-000022 |
| FY 2019 | $-5.1M | 2019-01-01 – 2019-12-31 | evidence 0001847903-22-000022 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CENTESSA PHARMACEUTICALS PLC — all facts · Revenue · Net Income